Innoterra Bioscience Profile
Key Indicators
- Authorised Capital ₹ 16.50 Cr
- Paid Up Capital ₹ 15.88 Cr
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 M
- Revenue Growth -40.88%
- Profit Growth 69.43%
- Ebitda 69.83%
- Net Worth 81.17%
- Total Assets 24.82%
About Innoterra Bioscience
Innoterra Bioscience Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 2010 and has a history of 14 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Innoterra Tech India Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.50 Cr and a paid-up capital of Rs 15.88 Cr.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Innoterra Bioscience Private Limited India is Pooja Gondalia as COMPANY SECRETARY. Satyajit Sarna and Anup Karwa serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U20211MH2010PTC205170
-
Company No.
205170
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jul 2010
-
Date of AGM
11 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Innoterra Bioscience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Gondalia | Company Secretary | 25-Mar-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyajit Sarna
|
Additional Director | 02-Apr-2024 | Current |
|
Anup Karwa
|
Director | 07-Jun-2023 | Current |
Financial Performance of Innoterra Bioscience.
Innoterra Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.88% decrease. The company also saw a substantial improvement in profitability, with a 69.43% increase in profit. The company's net worth Soared by an impressive increase of 81.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innoterra Bioscience?
In 2023, Innoterra Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Innoterra Platform Private LimitedSatyajit Sarna is a mutual person
-
Districo India Private LimitedSatyajit Sarna is a mutual person
-
Farmlink Agri Distribution And Market Linkage Private LimitedSatyajit Sarna is a mutual person
-
Innoterra India Private LimitedSatyajit Sarna is a mutual person
-
Sig India Trading Private LimitedPooja Gondalia is a mutual person
-
Agricrest Investment Advisors Private Limited
Satyajit Sarna is a mutual person
Charges (Loans)
₹0
₹0.15 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2011 | Bank Of India | ₹1.50 M | Satisfied |
How Many Employees Work at Innoterra Bioscience?
Unlock and access historical data on people associated with Innoterra Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innoterra Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoterra Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
